Biohaven (BHVN) Depreciation & Amortization (CF) (2021 - 2026)

Biohaven (BHVN) reported Depreciation & Amortization (CF) of $2.4 million for Q1 2026, up 5.34% on a YoY basis from $2.2 million in Q1 2025, and down 8.05% sequentially from $2.6 million in Q4 2025.

Biohaven (BHVN) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Biohaven (BHVN) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $2.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 5.34% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $10.0 million (up 16.03% YoY), and the FY2025 full-year result was $9.9 million, up 26.31% from the prior year.
  • Depreciation & Amortization (CF) eased to $2.4 million in Q1 2026, from $2.6 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $3.1 million in Q3 2025 to a low of $250000.0 in Q1 2022.
  • A 5-year average of $1.7 million and a median of $1.9 million in 2023 frame the typical range for Depreciation & Amortization (CF).
  • Across the five-year window, Depreciation & Amortization (CF) plunged 49.78% in 2022 and jumped 559.6% in 2023, its largest moves.
  • Tracing BHVN's Depreciation & Amortization (CF) over 5 years: stood at $344000.0 in 2022, then jumped by 450.58% to $1.9 million in 2023, then increased by 29.94% to $2.5 million in 2024, then rose by 4.55% to $2.6 million in 2025, then retreated by 8.05% to $2.4 million in 2026.
  • Business Quant data shows BHVN's Depreciation & Amortization (CF) at $2.4 million in Q1 2026, $2.6 million in Q4 2025, and $3.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 196,658.72
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 41.14 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 2.20 Mn
10 Biohaven 2.13 Bn 1.78 Bn - 2.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.37 Mn
Mar 31, 2026 2.37 Mn
Dec 31, 2025 2.57 Mn
Dec 31, 2025 2.57 Mn
Sep 30, 2025 3.13 Mn
Sep 30, 2025 3.13 Mn
Jun 30, 2025 1.98 Mn
Jun 30, 2025 1.98 Mn
Mar 31, 2025 2.25 Mn
Mar 31, 2025 2.25 Mn
Dec 31, 2024 2.46 Mn
Dec 31, 2024 2.46 Mn
Sep 30, 2024 1.99 Mn
Sep 30, 2024 1.99 Mn
Jun 30, 2024 1.95 Mn
Jun 30, 2024 1.95 Mn
Mar 31, 2024 1.45 Mn
Mar 31, 2024 1.45 Mn
Dec 31, 2023 1.89 Mn
Dec 31, 2023 1.89 Mn